AI-based Drug Discovery
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
36
NCT05791448
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
Phase: Phase 1
Role: Collaborator
Start: Mar 29, 2023
Completion: Mar 29, 2027
Loading map...